piribedil has been researched along with Tinnitus in 4 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
Tinnitus: A nonspecific symptom of hearing disorder characterized by the sensation of buzzing, ringing, clicking, pulsations, and other noises in the ear. Objective tinnitus refers to noises generated from within the ear or adjacent structures that can be heard by other individuals. The term subjective tinnitus is used when the sound is audible only to the affected individual. Tinnitus may occur as a manifestation of COCHLEAR DISEASES; VESTIBULOCOCHLEAR NERVE DISEASES; INTRACRANIAL HYPERTENSION; CRANIOCEREBRAL TRAUMA; and other conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the efficacy and safety of the dopaminergic drug piribedil for the treatment of tinnitus and to evaluate whether ECoG and acoustic otoemissions might be useful for predicting treatment response." | 9.14 | Tinnitus treatment with piribedil guided by electrocochleography and acoustic otoemissions. ( de Azevedo, AA; de Oliveira, PM; Langguth, B; Rodrigues Figueiredo, R, 2009) |
| "To assess the efficacy and safety of the dopaminergic drug piribedil for the treatment of tinnitus and to evaluate whether ECoG and acoustic otoemissions might be useful for predicting treatment response." | 5.14 | Tinnitus treatment with piribedil guided by electrocochleography and acoustic otoemissions. ( de Azevedo, AA; de Oliveira, PM; Langguth, B; Rodrigues Figueiredo, R, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Azevedo, AA | 1 |
| Langguth, B | 1 |
| de Oliveira, PM | 1 |
| Rodrigues Figueiredo, R | 1 |
| Hastak, SM | 1 |
| Haguenauer, JP | 1 |
| Agnoli, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Tinnitus Treatment With Piribedil Guided by Acoustic Otoemissions and Electrocochleography[NCT00591994] | 100 participants (Actual) | Interventional | 2006-11-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for piribedil and Tinnitus
| Article | Year |
|---|---|
Tinnitus treatment with piribedil guided by electrocochleography and acoustic otoemissions.
Topics: Aged; Audiometry, Evoked Response; Cross-Over Studies; Dopamine Agents; Double-Blind Method; Female; | 2009 |
Treatment of memory impairment, vertigo and tinnitus in the elderly with piribedil in an Indian general practice setting.
Topics: Aged; Aged, 80 and over; Dopamine Agonists; Family Practice; Female; Humans; India; Male; Memory Dis | 2003 |
2 other studies available for piribedil and Tinnitus
| Article | Year |
|---|---|
[Trivastan in otorhinolaryngology].
Topics: Adolescent; Adult; Aged; Deafness; Humans; Meniere Disease; Middle Aged; Otorhinolaryngologic Diseas | 1976 |
[Problems in the long-term medical treatment of sequelae of acute cerebrovascular diseases. Double-blind studies].
Topics: Cerebrovascular Disorders; Cognition Disorders; Emotions; Headache; Humans; Mental Processes; Motor | 1976 |